Information

Vildagliptin is a DPP-4 inhibitor API used for the treatment of Type 2 Diabetes Mellitus. It works by increasing incretin hormone levels, which enhances insulin secretion and reduces glucagon release in a glucose-dependent manner, helping to achieve better glycemic control. It is commonly used alone or in combination with other antidiabetic medications.

Log in

See all the content and easy-to-use features by logging in or registering!